Overview
A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)
Status:
Completed
Completed
Trial end date:
2003-02-01
2003-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study will look at the effectiveness of MK0777 in patients with Generalized Anxiety Disorder.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.
Criteria
Inclusion Criteria:- Male or Female
- Current diagnosis of Generalized Anxiety Disorder
- Age 18 - 70
Exclusion Criteria:
- Women who are pregnant, or breast-feeding
- Use of illicit drugs
- History of drug or alcohol dependence